.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Anti-HIV drug now indicated to treat chronic hepatitis B

September 15, 2008

Chronic hepatitis B can now be treated with a new drug.

Key Points

Known as the silent killer because it can persist for years without showing symptoms, chronic hepatitis B can now be treated with a new drug. Gilead Sciences' Viread (tenofovir disoproxil fumarate) was approved in 2001 to treat HIV. Chronic hepatitis B is a liver disease that disproportionately affects Asian Americans and is the leading cause of liver cancer worldwide. Complications from the disease can kill one in four of those affected.